Israel - englanti - Ministry of Health

medison pharma ltd - tipiracil as hydrochloride; trifluridine - film coated tablets - tipiracil as hydrochloride 6.14 mg; trifluridine 15 mg - trifluridine, combinations - colorectal cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.gastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Israel - englanti - Ministry of Health

medison pharma ltd - tipiracil as hydrochloride; trifluridine - film coated tablets - tipiracil as hydrochloride 6.14 mg; trifluridine 15 mg - trifluridine, combinations - colorectal cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.gastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Israel - englanti - Ministry of Health

medison pharma ltd - tipiracil as hydrochloride; trifluridine - film coated tablets - tipiracil as hydrochloride 8.19 mg; trifluridine 20 mg - trifluridine, combinations - colorectal cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.gastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Israel - englanti - Ministry of Health

medison pharma ltd - tipiracil as hydrochloride; trifluridine - film coated tablets - tipiracil as hydrochloride 8.19 mg; trifluridine 20 mg - trifluridine, combinations - colorectal cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.gastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Kanada - englanti - Health Canada

taiho pharma canada, inc. - trifluridine; tipiracil (tipiracil hydrochloride) - tablet - 15mg; 6.14mg - trifluridine 15mg; tipiracil (tipiracil hydrochloride) 6.14mg - antineoplastic agents

Kanada - englanti - Health Canada

taiho pharma canada, inc. - trifluridine; tipiracil (tipiracil hydrochloride) - tablet - 20mg; 8.19mg - trifluridine 20mg; tipiracil (tipiracil hydrochloride) 8.19mg - antineoplastic agents

Yhdysvallat - englanti - NLM (National Library of Medicine)

taiho pharmaceutical co., ltd. - trifluridine (unii: rmw9v5rw38) (trifluridine - unii:rmw9v5rw38), tipiracil hydrochloride (unii: 4h59klq0a4) (tipiracil - unii:ngo10k751p) - trifluridine 15 mg - lonsurf, as a single agent or in combination with bevacizumab, is indicated for the treatment of adult patients with metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf biological therapy, and if ras wild-type, an anti-egfr therapy. lonsurf is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, her2/neu-targeted therapy. none. risk summary based on animal data and its mechanism of action [see clinical pharmacology (12.2)] , lonsurf can cause fetal harm. lonsurf caused embryo-fetal lethality and embryo-fetal toxicity in pregnant rats when given during gestation at doses resulting in exposures lower than or similar to human exposures at the recommended clinical dose (see data) . there are no available data on

Yhdysvallat - englanti - NLM (National Library of Medicine)

greenstone llc - trifluridine (unii: rmw9v5rw38) (trifluridine - unii:rmw9v5rw38) - trifluridine 1 g in 100 ml

Kanada - englanti - Health Canada

apotex inc - trifluridine - solution - 1% - trifluridine 1% - antivirals

Yhdysvallat - englanti - NLM (National Library of Medicine)

sandoz inc - trifluridine (unii: rmw9v5rw38) (trifluridine - unii:rmw9v5rw38) - indications and usage: trifluridine ophthalmic solution is indicated for the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2. contraindications: trifluridine ophthalmic solution is contraindicated for patients who develop hypersensitivity reactions or chemical intolerance to trifluridine.